Log in to save to my catalogue

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental...

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2673845

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

About this item

Full title

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2009-05, Vol.119 (5), p.1298-1311

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Idiopathic pulmonary fibrosis (IPF) can lead to the development of secondary pulmonary hypertension (PH) and ultimately death. Despite this known association, the precise mechanism of disease remains unknown. Using a rat model of IPF, we explored the role of the proangiogenic and antiapoptotic growth factor VEGF in the vascular remodeling that unde...

Alternative Titles

Full title

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2673845

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2673845

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI36136

How to access this item